MEDIFAST INC
MED
Positions held
Your positionsMED isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $127.80M | Enterprise value | -$24.03M | Trailing P/E | — | Forward P/E | -40.82 |
| PEG | 0.97 | Price / book | 0.60 | Beta | 0.70 | Dividend yield | 0.00% |
| Revenue growth | -27.6% | Earnings growth | — | Gross margin | 69.2% | Operating margin | -5.7% |
| Profit margin | -8.1% | ROE | -12.4% | ROA | -4.6% | Debt / equity | 0.14 |
| Current ratio | 4.86 | Free cash flow | $11.37M | Analyst recommendation | none | Mean target | $12.00 |
| 52w high | $14.06 | 52w low | $9.22 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $76.4M | $76.0M | $75.1M | $89.4M | $106M | — |
| Op margin | -5.7% | -4.3% | -10.4% | -4.6% | -1.0% | — |
| Net income | -$3.1M | -$2.1M | -$18.1M | -$2.3M | $2.5M | — |
| Gross margin | 69.9% | 68.1% | 69.4% | 69.5% | 72.6% | — |
| Gross profit | $53.4M | $51.8M | $52.1M | $62.2M | $76.6M | — |
| Operating income | -$4.3M | -$3.3M | -$7.8M | -$4.1M | -$1.1M | — |
- Revenue +0% vs prior quarter ($76M vs $76M).
- Gross margin 69.9% (was 68.1% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $386M | $602M | $1.1B | $1.6B | — |
| Op margin | -3.7% | 0.5% | 11.8% | 11.6% | — |
| Net income | -$18.7M | $2.1M | $99.4M | $144M | — |
| Gross margin | 71.3% | 73.8% | 72.4% | 71.3% | — |
| Gross profit | $275M | $445M | $776M | $1.1B | — |
| Operating income | -$14.2M | $2.9M | $126M | $185M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · What Actually Keeps Weight Off After a Weight Loss Program
2026-10-07 · Can Hormel Foods Tackle Input Costs With Pricing and Efficiency?
2026-10-06 · Can Medifast's Better Client Retention Support Revenue Stabilization?
2026-10-06 · Why Do You Keep Gaining Weight Back After Losing It
2026-10-01 · Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment
2026-10-01 · Will Innovation and Digital Expansion Efforts Drive Clorox's Growth?
2026-10-01 · Here's Why Shares of BranchOut Food Surge 89% in a Year
2026-10-01 · What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
2026-09-29 · Hormel Foods Pricing Strategy: Can It Balance Value and Profitability?
2026-09-29 · Why Weight Loss Plateaus Happen: 5 Metabolic Causes
2026-09-25 · Can Hormel Foods' Protein Portfolio Win Over Value-Seeking Consumers?
2026-09-24 · Boston Beer Uses Innovation, Pricing & Brand Investments for Growth
Price (daily)
Full chart · RSI · MACD · patterns